FDA official logo
GSRS logo
PFDA official logo

DAPAGLIFLOZIN

  • UNII: 1ULL0QJ8UC
  • Formula: C21H25ClO6
  • Preferred Substance Name: DAPAGLIFLOZIN
  • InChIKey: JVHXJTBJCFBINQ-ADAARDCZSA-N

  • 461432-26-8
  • (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL
  • BMS-512148
  • BR1019 COMPONENT DAPAGLIFLOZIN
  • DAPAGLIFLOZIN [INN]
  • DAPAGLIFLOZIN [MI]
  • DAPAGLIFLOZIN [ORANGE BOOK]
  • DAPAGLIFLOZIN [USAN]
  • DAPAGLIFLOZIN [VANDF]
  • DAPAGLIFLOZIN [WHO-DD]
  • DAPAGLIFLOZIN COMPONENT OF QTERNMET XR
  • DAPAGLIFLOZIN COMPONENT QTERNMET
  • D-GLUCITOL, 1,5-ANHYDRO-1-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-, (1S)-
  • LYN-045
  • QTERNMET COMPONENT DAPAGLIFOZIN
  • QTERNMET XR COMPONENT DAPAGLIFLOZIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.